Molecular Templates, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Posters
    • Articles
  • Pipeline
    • Overview
    • MT-6402
    • MT-8421
    • MT-0169
  • Clinical Trials
    • Overview
    • Expanded Access
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Contact
  • Careers

Press Releases

Investors

Investors

  • Overview
  • Presentations
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Email Alerts
  • News & Events - HIDDEN

  • Overview
  • Press Releases
  • IR Calendar

Molecular Templates Announces Presentations at the American Society of Hematology (ASH) 2019 Annual Meeting

Dec 09, 2019 10:00am EST

Molecular Templates to Present at Two December Investor Conferences

Nov 26, 2019 8:00am EST

Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering

Nov 21, 2019 7:00am EST

Molecular Templates, Inc. Announces Proposed Public Equity Offering

Nov 20, 2019 4:01pm EST

Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants

Nov 18, 2019 7:00am EST

Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results

Nov 12, 2019 5:00pm EST

Molecular Templates Hosting Analyst & Investor Meeting

Nov 07, 2019 4:27pm EST

Molecular Templates to Present at the Ladenburg ThalmannĀ and Cantor Fitzgerald Healthcare Conferences

Sep 23, 2019 4:30pm EDT

Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results

Aug 12, 2019 4:30pm EDT

Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38

Jun 17, 2019 8:00am EDT
RSS
  • Prev
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...13
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2023 Molecular Templates, Inc. All Rights Reserved.
    Twitter Linkedin
    Privacy Policy Disclaimer Terms of Use Sitemap Expanded Access